On-site Assessment of Blood/Exhaled Gas Ratio of Propofol in Humans by Means of GC-SAW

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-13003291

Enrollment

Unknown

Registered

2013-06-23

Start date

2013-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1:propofol

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All clinical studies were approved by Office of Human Research Protections (OHRP) at Zhejiang University with institutional review board IRB00005015. Written informed consents were obtained from 6 healthy volunteers and 28 patients. All of the participated patientshad been evaluated with American Society of Anesthesiologists physical status I or II.

Exclusion criteria

Exclusion criteria: Exclude of the pations with Contraindication to the use of propofol, Cardiac insufficiency, Pregnant women, Unstable blood pressure, Refuse to study

Design outcomes

Primary

Measure	Time frame
blood propofol concentrations;	—

Countries

China

Contacts

Public ContactMin Yan

yanminnina@hotmail.com+86 0571 87763716

Outcome results